Quick answer: CB1 is often discussed with the brain and nervous system. CB2 is often discussed with body-focused cannabinoid research. Both are part of the endocannabinoid system.
Older Cannabolix education talked a lot about the endocannabinoid system. That is still a strong lane, but the language needs to be careful.
CB1 and CB2 are not magic switches. They are receptors in a larger body signaling system.
| Receptor | Simple Education |
|---|---|
| CB1 | Often discussed with brain and nervous system signaling |
| CB2 | Often discussed with immune and body-focused research |
| ECS | A larger signaling network, not one product claim |
Why Customers Should Learn This
When customers understand receptors, they are less likely to fall for hype. They can see the difference between education and a medical claim.
A non-intoxicating phytocannabinoid.
The main intoxicating cannabis compound.
A terpene studied for CB2 receptor activity.
Where Cannabolix Fits
For topicals, keep the claim centered on cooling support and targeted application. Use receptor education as background, not as a treatment promise.
Claim-Safe Takeaway
Cannabolix can teach the science without promising to treat pain, injury, inflammation, arthritis, disease, or guaranteed results. The strongest customer message is simple: targeted cooling support, clean roll-on application, CBD isolate, and 0% THC product education.
References
- Pharmacology of cannabinoid CB1 and CB2 receptors. PubMed PMID: 9336020. https://pubmed.ncbi.nlm.nih.gov/9336020/
- Endocannabinoid System: Chemical Characteristics and Biological Activity. PubMed PMID: 37017445. https://pubmed.ncbi.nlm.nih.gov/37017445/
0 comments